Deutsche Bank AG Grows Position in Astera Labs, Inc. (NASDAQ:ALAB)

Deutsche Bank AG increased its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 2,448.4% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 196,103 shares of the company’s stock after buying an additional 188,408 shares during the quarter. Deutsche Bank AG owned about 0.12% of Astera Labs worth $11,701,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Astera Labs by 2,824.4% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 154,524 shares of the company’s stock valued at $20,467,000 after buying an additional 149,240 shares in the last quarter. Pacific Point Advisors LLC grew its stake in shares of Astera Labs by 75.0% in the first quarter. Pacific Point Advisors LLC now owns 7,000 shares of the company’s stock valued at $418,000 after buying an additional 3,000 shares in the last quarter. Oppenheimer Asset Management Inc. grew its stake in shares of Astera Labs by 73.6% in the first quarter. Oppenheimer Asset Management Inc. now owns 15,995 shares of the company’s stock valued at $954,000 after buying an additional 6,783 shares in the last quarter. Taylor Frigon Capital Management LLC acquired a new stake in shares of Astera Labs in the first quarter valued at about $1,887,000. Finally, Cetera Investment Advisers acquired a new stake in shares of Astera Labs in the fourth quarter valued at about $460,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Trading Down 1.5%

Shares of NASDAQ ALAB opened at $190.69 on Friday. The company has a market cap of $31.70 billion, a price-to-earnings ratio of 340.52, a price-to-earnings-growth ratio of 4.91 and a beta of 1.39. Astera Labs, Inc. has a 12-month low of $36.85 and a 12-month high of $199.47. The stock’s 50 day simple moving average is $113.59 and its 200 day simple moving average is $89.51.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $0.11. The business had revenue of $191.93 million for the quarter, compared to the consensus estimate of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%. The business’s revenue was up 149.5% on a year-over-year basis. During the same quarter last year, the business posted $0.13 EPS. As a group, equities analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the company. Stifel Nicolaus set a $145.00 target price on Astera Labs and gave the company a “buy” rating in a research note on Monday, August 4th. Roth Capital set a $100.00 price objective on Astera Labs and gave the company a “buy” rating in a research note on Wednesday, May 7th. Evercore ISI raised their price objective on Astera Labs from $104.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday, August 6th. Susquehanna raised their price objective on Astera Labs from $80.00 to $125.00 and gave the company a “neutral” rating in a research note on Thursday, August 7th. Finally, Northland Capmk lowered Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 22nd. Four analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $129.13.

Insiders Place Their Bets

In related news, Director Stefan A. Dyckerhoff sold 25,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $173.42, for a total value of $4,335,500.00. Following the sale, the director owned 99,154 shares of the company’s stock, valued at approximately $17,195,286.68. This trade represents a 20.14% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Michael Truett Tate sold 100,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $191.19, for a total value of $19,119,000.00. Following the completion of the sale, the chief financial officer directly owned 401,496 shares in the company, valued at approximately $76,762,020.24. This trade represents a 19.94% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 2,329,686 shares of company stock worth $273,512,376. 12.50% of the stock is currently owned by insiders.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.